|
Market Closed -
Nasdaq
16:00:00 2026-10-06 EDT
|
5-day change | 1st Jan Change | ||
| 18.58 USD | +2.65% |
|
+11.46% | +95.79% |
| 08-13 | Fortress Biotech, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| 08-13 | Fortress Biotech, Inc., Q2 2026 Earnings Call, Aug 12, 2026 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FORTRESS BIOTECH, INC. | Biopharmaceuticals | +2.65% | +11.46% | +95.79% | +150.74% | -27.90% | 68.37M |
-
|
-
|
-
|
- Stock Market
- Stocks
- FBIO Stock
- FBIOP Stock
- Charts Fortress Biotech, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
